1. Home
  2. NCRA vs AYTU Comparison

NCRA vs AYTU Comparison

Compare NCRA & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCRA
  • AYTU
  • Stock Information
  • Founded
  • NCRA 2002
  • AYTU N/A
  • Country
  • NCRA Taiwan
  • AYTU United States
  • Employees
  • NCRA N/A
  • AYTU N/A
  • Industry
  • NCRA Farming/Seeds/Milling
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCRA Consumer Staples
  • AYTU Health Care
  • Exchange
  • NCRA Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • NCRA 12.6M
  • AYTU 9.8M
  • IPO Year
  • NCRA N/A
  • AYTU N/A
  • Fundamental
  • Price
  • NCRA $0.82
  • AYTU $1.38
  • Analyst Decision
  • NCRA
  • AYTU
  • Analyst Count
  • NCRA 0
  • AYTU 0
  • Target Price
  • NCRA N/A
  • AYTU N/A
  • AVG Volume (30 Days)
  • NCRA 8.4K
  • AYTU 37.2K
  • Earning Date
  • NCRA 08-14-2024
  • AYTU 02-12-2025
  • Dividend Yield
  • NCRA N/A
  • AYTU N/A
  • EPS Growth
  • NCRA N/A
  • AYTU N/A
  • EPS
  • NCRA N/A
  • AYTU N/A
  • Revenue
  • NCRA $20,483,694.00
  • AYTU $79,759,000.00
  • Revenue This Year
  • NCRA N/A
  • AYTU N/A
  • Revenue Next Year
  • NCRA N/A
  • AYTU N/A
  • P/E Ratio
  • NCRA N/A
  • AYTU N/A
  • Revenue Growth
  • NCRA N/A
  • AYTU N/A
  • 52 Week Low
  • NCRA $0.70
  • AYTU $1.30
  • 52 Week High
  • NCRA $1.54
  • AYTU $3.45
  • Technical
  • Relative Strength Index (RSI)
  • NCRA 41.47
  • AYTU 33.90
  • Support Level
  • NCRA $0.76
  • AYTU $1.30
  • Resistance Level
  • NCRA $1.14
  • AYTU $1.47
  • Average True Range (ATR)
  • NCRA 0.11
  • AYTU 0.12
  • MACD
  • NCRA -0.01
  • AYTU -0.01
  • Stochastic Oscillator
  • NCRA 35.82
  • AYTU 17.78

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Share on Social Networks: